- Home
- RFL vs BUDA Comparison
RFL vs BUDA Comparison
Compare RFL & BUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFL | BUDA |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | 39 |
| Industry | Real Estate | Beverages (Production/Distribution) |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6M | 91.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | RFL | BUDA |
|---|---|---|
| Price | $2.14 | $9.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 307.5K | 20.2K |
| Earning Date | 06-10-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $917,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.42 |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $6.25 |
| 52 Week High | $3.96 | $12.00 |
Technical Indicators
Market Signals| Indicator | RFL | BUDA |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 51.30 |
| Support Level | $1.21 | $9.10 |
| Resistance Level | $3.96 | $10.42 |
| Average True Range (ATR) | 0.37 | 0.81 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 0.47 | 31.51 |
Price Performance
Historical ComparisonAbout RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
About BUDA Buda Juice Inc. Common Stock
Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.